Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Relative fitness of hematopoietic progenitors influences leukemia progression.

Porter CC, Baturin D, Choudhary R, DeGregori J.

Leukemia. 2011 May;25(5):891-5. doi: 10.1038/leu.2011.22. Epub 2011 Feb 18. No abstract available.

2.

Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.

Chan G, Kalaitzidis D, Usenko T, Kutok JL, Yang W, Mohi MG, Neel BG.

Blood. 2009 Apr 30;113(18):4414-24. doi: 10.1182/blood-2008-10-182626. Epub 2009 Jan 29.

3.

The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.

Ritchie KA, Aprikyan AA, Bowen-Pope DF, Norby-Slycord CJ, Conyers S, Bartelmez S, Sitnicka EH, Hickstein DD.

Leukemia. 1999 Nov;13(11):1790-803.

PMID:
10557054
4.
5.
6.

[Proliferation and differentiation of cells and differentiation- inducing treatment in leukemia].

Kuliczkowski K.

Pol Arch Med Wewn. 1992 Jul;88(1):49-56. Polish. No abstract available.

PMID:
1454660
7.
8.

Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.

Richter K, Pinto do O P, Hägglund AC, Wahlin A, Carlsson L.

Haematologica. 2003 Dec;88(12):1336-47.

9.

NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.

Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G.

EMBO J. 2001 Feb 1;20(3):350-61.

10.

Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.

Johnson JJ, Chen W, Hudson W, Yao Q, Taylor M, Rabbitts TH, Kersey JH.

Blood. 2003 Apr 15;101(8):3229-35. Epub 2002 Dec 19.

11.
12.

Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice.

Fenske TS, Pengue G, Mathews V, Hanson PT, Hamm SE, Riaz N, Graubert TA.

Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15184-9. Epub 2004 Oct 11.

13.

In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.

Greenberg PL.

Clin Haematol. 1986 Nov;15(4):973-93. Review. No abstract available.

PMID:
3552351
14.

Both myeloproliferative disease and leukemia are induced by transplantation of bone marrow cells expressing v-myc.

Bonham L, MacKenzie K, Wood S, Rowe PB, Symonds G.

Oncogene. 1992 Nov;7(11):2219-29. Erratum in: Oncogene 1993 May;8(5):1403.

PMID:
1437146
15.

Culture studies in vitro in human leukemia.

Spitzer G, Verma DS, Dicke KA, McCredie KB.

Semin Hematol. 1978 Oct;15(4):352-78. Review. No abstract available.

PMID:
366760
16.

[Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].

Takahashi M, Fujiwara M.

Rinsho Ketsueki. 1988 Jul;29(7):994-1000. Japanese. No abstract available.

PMID:
3184486
17.

Characterization of murine JAK2V617F-positive myeloproliferative disease.

Bumm TG, Elsea C, Corbin AS, Loriaux M, Sherbenou D, Wood L, Deininger J, Silver RT, Druker BJ, Deininger MW.

Cancer Res. 2006 Dec 1;66(23):11156-65.

18.

Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.

Preisler HD.

Cancer Treat Res. 2001;108:185-230. Review. No abstract available.

PMID:
11702600
19.

The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.

Das M, Chatterjee S, Basak P, Das P, Pereira JA, Dutta RK, Chaklader M, Chaudhuri S, Law S.

J Stem Cells. 2010;5(2):49-64.

PMID:
22049615
20.

Effect of a transplantable leukemia on hematopoietic stem cells in AKR mice.

Nakeff A, Valeriote FA.

Cancer Treat Rep. 1978 May;62(5):737-41.

PMID:
657159

Supplemental Content

Support Center